0

0

5

6

7

8

9

9

Global Ecosystem

Signals Group is advancing global health by combining insights, analysis, research, and media to shape what’s possible in kidney care

Driving Change
In Depth
Your source for data driven insights shaping the future of kidney care
Post Image

We Are Here: 5 Charts That Explain Kidney Care

From awareness to access, and dialysis to donation, here’s what’s actually changing— and where we're still stuck.

Kidney Care Navigators Image

Wanted: Kidney Care Navigators

Cancer care made navigation standard. Is kidney care next?

Life on immunosuppression image

Life on Immunosuppression

The largest survey of its kind reveals the daily toll of transplant drugs — and the case for rewriting the playbook through advocacy, policy, and innovation

Kidney Capital, Pt. 1

Data from 14 of the most active kidney investors from idea to IPO

Dummy image

Community

Connect with a global group of your peers

Get firsthand knowledge on topics across care delivery, industry, academia, advocacy, policy, and more.

About

The future of kidney health impacts all of us. We aim to shape what comes next.

Signals Group leverages media and research to advance a shared mission. Together with our partners, we explore the ideas, innovations, and investments shaping kidney, cardio, and metabolic health.

Through our flagship newsletter, community, and advisory work, we highlight opportunities, share knowledge, and connect people shaping the future of care.

Founded by Tim Fitzpatrick, Signals Group builds on a decade of experience at the frontlines of kidney health and innovation. Tim’s work spans entrepreneurship, media, and storytelling — creating new ways for patients, clinicians, and industry leaders to learn, connect, and drive progress.

Beyond Signals, Tim is a serial entrepreneur who writes and speaks regularly about innovation, health, and the future of care delivery.

Kidney Verse

Latest From Linkedin

The Central Question Of Our Time

Will we find better ways to balance kidney health and costs in 2025?

If You Had $1 Million To Solve One Problem

What problem would you tackle, what would you build, and who would you build it with?

FDA Approves Xeno Clinical Trials

A discussion on new hope for tens of thousands of people with kidney failure awaiting an organ transplant...

The biggest story in the world

Understanding the devastating and still poorly understood epidemic of chronic kidney disease that is killing tens of thousands of young men in El Salvador, Nicaragua, Sri Lanka, India, and beyond.